Neuroectodermal Tumors  >>  epirubicin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00025441: Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

Completed
2
Europe
dactinomycin, filgrastim, carboplatin, cyclophosphamide, doxorubicin hydrochloride, epirubicin hydrochloride, etoposide, ifosfamide, vincristine sulfate, peripheral blood stem cell transplantation, radiation therapy
Societe Internationale d'Oncologie Pediatrique, Children's Cancer and Leukaemia Group, Societe Francaise Oncologie Pediatrique
Ovarian Cancer, Sarcoma, Small Intestine Cancer
 
03/10
NCT00755976 / 2006-006051-12: Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

Completed
2
32
Europe
epirubicin hydrochloride, sulindac, immunologic technique
Cancer Trials Ireland
Melanoma (Skin)
05/10
05/10

Download Options